Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Bernard Rubin's publication output changed over time?
ScholarIQpublication output · 1957–2024
Output grew0% over the shown period — from 1 works in 1957 to 1 in 2024.
1
1
2
1
3
1
1
1
1
195719701972197719781979198020232024
What are the most-cited papers on Bernard Rubin?
ScholarIQmost cited works
Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
Miguel A. Ondetti, Bernard Rubin, David W. Cushman
Science. 19771,865 Citations
Production and Evaluation of Antibodies for the Radioimmunoassay of Gastrin
Jens F. Rehfeld, F. Stadil, Bernard Rubin
S5501027. 1972428 Citations
SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
Bernard Rubin, Robert J. Laffan, D G Kotler, Eugene O’Keefe, D Demaio, M.E. Goldberg
S102125482. 1978210 Citations
Cholecystokinin-pancreozymin
Miguel A. Ondetti, Bernard Rubin, Stanford L. Engel, J. PLUSCEC, John T. Sheehan
Digestive Diseases and Sciences. 1970182 Citations
Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.
Robert J. Laffan, M.E. Goldberg, John P. High, Thomas Schaeffer, Miranda Waugh, Bernard Rubin
S102125482. 1978173 Citations
Related on ScholarIQ
Oklahoma City University
Institution
Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
Paper
Production and Evaluation of Antibodies for the Radioimmunoassay of Gastrin
Paper
SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
Paper
Cholecystokinin-pancreozymin
Paper
Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.
Paper